The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index; 55 of the 89 sources its claims cite were checked for support.
Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review
Open accessAbstract
Musculoskeletal injuries are a prevalent cause of disability, often impairing daily function and overall well-being. Standard treatments – including physiotherapy, anti-inflammatory medications, and surgery – frequently fall short in achieving optimal outcomes. Regenerative strategies, particularly platelet-rich plasma (PRP) and stem cell (SC) therapies, have emerged as alternatives due to their biological capacity to promote tissue regeneration and repair. This systematic review synthesizes evidence from randomized controlled trials that compare PRP and SC interventions with conventional management of musculoskeletal injuries. Literature was systematically searched in PubMed, Embase, and LILACS for relevant studies published through a structured search strategy. A total of 23 studies met the eligibility criteria. Findings indicate that PRP facilitates early pain relief and functional gains, while SC therapies contribute to sustained regenerative effects. When used in combination, PRP and SC demonstrated enhanced clinical outcomes. Although no serious adverse events were consistently reported, marked heterogeneity in protocols and outcomes was observed. Risk of bias varied across studies, highlighting the need for methodological rigor. Overall, the evidence suggests that PRP and SC therapies hold potential for musculoskeletal repair. However, standardized protocols and further robust clinical trials are essential to confirm their safety, efficacy, and broader applicability.
Overview
CoChat Summary
TL;DR
This systematic review of 23 randomized controlled trials found that platelet-rich plasma (PRP) and stem cell therapies generally improved pain and function more than conventional treatments for musculoskeletal injuries. The authors conclude these biologic therapies are promising, but heterogeneity and bias limit definitive conclusions.
Key findings
- The search identified 437 records; after screening, 23 studies met inclusion criteria.
- Across the included RCTs, PRP and/or stem cell therapies were associated with improvements in pain and function in several conditions, including knee osteoarthritis, rotator cuff tendinopathy, Achilles tendinopathy, and degenerative disc disease.
- Reported effect estimates included, for example, MSC ± PRP vs corticosteroids in knee OA with pain reduction Δ23.2 (P < 0.001) and functional improvement Δ24.0 (P = 0.002) at 12 months, and PRP vs corticosteroids in high tibial osteotomy patients with global KOOS Δ +40 points (P < 0.05) and VAS Δ -5 points (P < 0.05).
- Risk of bias was substantial: 10 studies (43.5%) were rated high risk of bias, and 13 (56.5%) had some concerns.
Methods
- Systematic review conducted following PRISMA guidelines; included randomized controlled trials comparing PRP and/or mesenchymal stem cells with conventional treatments for musculoskeletal injury repair.
- Databases searched: MEDLINE (PubMed), Embase, and LILACS; studies were limited to English and Spanish and reference lists were also checked.
- Outcomes extracted included pain reduction, functional improvement, time to return to activity, adverse events, additional procedures, and quality of life; study quality was assessed with Cochrane RoB 2.0.
Limitations
- The paper states that methodological limitations and protocol heterogeneity limit the ability to draw definitive conclusions.
- The authors also note differences in PRP preparation, MSC sources, doses, delivery routes, and outcome measures, which limited comparability and pooled interpretation.
- Evident from the text: nearly half of the included studies had high risk of bias (10/23), and the review restricted inclusion to English and Spanish studies, which may have excluded relevant evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
49 Valid · 8 Not valid · 27 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“which showed no significant improvements. [12]”
What the sources say
- Disputedcites [12] Nguyen, 2016, Comparative clinical observation of arthroscopic microfracture in the presence and absence of a stromal vascular fraction injection for osteoarthritis, Stem Cell Transl Med J sourceExperimental — accuracy not yet measured
The Discussion (page unavailable in our copy) says arthroscopic microfracture alone significantly reduced pain and improved knee function at six months, with benefits persisting through 12 months. It also says that symptoms in most patients returned to pretreatment levels by 18 months. The claim that microfracture alone showed no significant improvements omits those earlier improvements. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Similarly, Mormone et al. showed that BMAC obtained from the iliac crest and proximal tibia had a greater impact on pain reduction and functional improvement compared to PRP ( P < 0.001 for both V AS and WOMAC). [20]”
What the sources say
- Disputedcites [20] Mormone, 2024, Posterior iliac crest vs. Proximal tibia: Distinct sources of anti-inflammatory and regenerative cells with comparable 6-month clinical outcomes in treatment of osteoarthritis, J Transl Med sourceExperimental — accuracy not yet measured
The Results section (“Primary outcome parameters: BMA vs PRP treatment”) reports significant WOMAC improvements within the treatment arms, but says the reductions did not differ significantly across arms. The Discussion (“Clinical outcomes”) likewise states that neither iliac-crest nor tibial treatment was superior to PRP at six months. Thus, P < 0.001 does not establish the claimed greater functional improvement compared with PRP. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Similarly, Mormone et al. showed that BMAC obtained from the iliac crest and proximal tibia had a greater impact on pain reduction and functional improvement compared to PRP ( P < 0.001 for both V AS and WOMAC). [20]”
What the sources say
- Disputedcites [20] Mormone, 2024, Posterior iliac crest vs. Proximal tibia: Distinct sources of anti-inflammatory and regenerative cells with comparable 6-month clinical outcomes in treatment of osteoarthritis, J Transl Med sourceExperimental — accuracy not yet measured
The Results (Primary outcome parameters: BMA vs PRP treatment) report significant VAS and WOMAC improvements within the treatment arms, but no significant difference in reductions across the three arms. The cited P < 0.001 values are within-arm results, not evidence that iliac-crest or tibial BMA outperformed PRP. The Discussion (Clinical outcomes) likewise says the study did not find BMA superior to PRP. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“with greater satisfaction reported in these groups compared to hyaluronic acid and ozone therapy.”
What the sources say
- Not checked yetcites [14] Angoorani, 2015, Treatment of knee osteoarthritis with platelet-rich plasma in comparison with transcutaneous electrical nerve stimulation plus exercise: A randomized clinical trial, Med J Islam Repub Iran
- Disputedcites [15] Raeissadat, 2017, Efficacy of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: A single-blinded randomized clinical trial, Clin Med Insights Arthritis Musculoskelet Disord sourceExperimental — accuracy not yet measured
The Results > Outcomes section (Table 3; page not provided) reports the same mean satisfaction score, 2.7, for PRGF and hyaluronic acid, with no significant difference (P = .726). This trial did not compare satisfaction with PRP or ozone therapy. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“WOMAC: PRGF Δ-37.1%; PRP Δ-36.2%; Ozone Δ-14.9%.”
What the sources say
- Disputedcites [26] Raeissadat, 2021, The comparison effects of intra-articular injection of platelet rich plasma (PRP), plasma rich in growth factor (PRGF), hyaluronic acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial, BMC Musculoskelet Disord sourceExperimental — accuracy not yet measured
Table 2 in the Results reports a 36.50% reduction in total WOMAC score for PRP from baseline to 12 months, not 36.2%. This is a within-group change; the between-group comparisons in Table 3 report mean differences rather than the claimed percentage. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
75 more claims · 34 with their cited sources checked
Create a free account to see all 113 claims and to verify the 7 references still open.
- It may state two separate claims as one. 13
- The quote only partly states this claim. 11
- Probably not a substantial claim. 12
Citations
Cites
Chahla, J., Cinque, M. E., Piuzzi, N. S., Mannava, S., Geeslin, A. G., Murray, I. R., Dornan, G. J., Muschler, G. F., & LaPrade, R. F. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.01374 · Cited by 504
Lee, W.-S., Kim, H. J., Kim, K.-I., Kim, G. B., & Jin, W. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0122 · Cited by 497
Wong, K. L., Lee, K. B. L., Tai, B. C., Law, P., Lee, E. H., & Hui, J. H. P. (2013) · Arthroscopy · doi:10.1016/j.arthro.2013.09.074 · Cited by 394
Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis
Koh, Y.-G., & Choi, Y.-J. (2012) · The Knee · doi:10.1016/j.knee.2012.04.001 · Cited by 392
Thanasas, C., Papadimitriou, G., Charalambidis, C., Paraskevopoulos, I., & Papanikolaou, A. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511417113 · Cited by 351
Raeissadat, S. A., Rayegani, S. M., Hassanabadi, H., Fathi, M., Ghorbani, E., Babaee, M., & Azma, K. (2015) · Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders · doi:10.4137/cmamd.s17894 · Cited by 331
Hurley, E. T., Lim Fat, D., Moran, C. J., & Mullett, H. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546517751397 · Cited by 223
Garza, J. R., Campbell, R. E., Tjoumakaris, F. P., Freedman, K. B., Miller, L. S., Santa Maria, D., & Tucker, B. S. (2020) · The American Journal of Sports Medicine · doi:10.1177/0363546519899923 · Cited by 200
Platelet-rich therapies for musculoskeletal soft tissue injuries
de Moraes, V. Y., Lenza, M., Tamaoki, M. J. S., Faloppa, F., & Belloti, J. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010071.pub2 · Cited by 183
Raeissadat, S. A., Ghazi Hosseini, P., Bahrami, M. H., Salman Roghani, R., Fathi, M., Gharooee Ahangar, A., & Darvish, M. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04017-x · Cited by 181
Research works printed but not linked: 1
- Angoorani, 2015, Treatment of knee osteoarthritis with platelet-rich plasma in comparison with transcutaneous electrical nerve stimulation plus exercise: A randomized clinical trial, Med J Islam Repub Iran, 29, 223
Metadata
- Authors
- Ballesta, F. J. G., Vásquez, L. N. A., Borbón, J. R., Leal, J. A. C., Agudelo, D. S. J., & Granados, J. P. A.
- Affiliations
- Department of Epidemiology, Universidad Autonoma de Bucaramanga, Bogota, Colombia,
- Universidad Industrial de Santander (CO)
- Universidad de La Sabana (CO)
- Universidad De Santander (CO)
- Department of Medicine, Universidad Coperativa de Medellín, Medellín, Colombia,
- Universidad Nacional de Colombia (CO)
- Venue
- Journal of Musculoskeletal Surgery and Research
- Publisher
- Scientific Scholar
- Published
- 2025-12-30
- Volume
- 10
- Pages
- 138-146
- ISSN
- 2589-1219 (ISSN-L)
- 2589-1227
- OpenAlex
- W7117533581
- Cited by
- 0
- References
- 30
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Journal of Musculoskeletal Surgery and Research (publishedVersion, cc-by-nc-sa)
- Topics
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- platelet-rich plasma, stem cell therapy, musculoskeletal injuries, tissue regeneration, regenerative medicine, conventional therapy comparison, analgesia, functional recovery, treatment protocols, treatment efficacy and safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review. https://app.cochat.ai/papers/10.25259/jmsr_402_2025
- The paper
- Ballesta, F. J. G., Vásquez, L. N. A., Borbón, J. R., Leal, J. A. C., Agudelo, D. S. J., & Granados, J. P. A. (2025). Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review. Journal of Musculoskeletal Surgery and Research. https://doi.org/10.25259/jmsr_402_2025
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.